Clinical Trial: Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome

Brief Summary: Poly cystic ovary syndrome (PCOS) is a disease which is prevalent in women of reproductive age facing obesity along with increased risk of type-2 diabetes and high cholesterol levels. The genetically determined cause of the PCOS includes disturbed levels of insulin and androgens. Standardized fenugreek seed extract (Furocyst) contains compounds such as saponins & flavonoids which act on the insulin and indirectly helps to regulate the androgen levels in the body.